In parallel, both accumulation of GABA, whose concentration is low in astrocytes under physiological circumstances [234], and its release from reactive astrocytes have been observed in transgenic animal models of AD (5xFAD and APP/PS1 mice), resulting in memory deficits [235,236]. This evidence concerns the gene APP and Alzheimer disease.